Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis
Early combination therapy showed a favourable impact on a composite outcome (including mortality, hospitalizations and access to emergency department) in severely immunocompromised hosts who were all vaccinated. However, further studies are needed to support our results.
Authors
- Vincenzo Scaglione (ORCID: https://orcid.org/0000-0002-2911-2255)
- Maria Mazzitelli (ORCID: https://orcid.org/0000-0003-0263-0703)
- Eleonora Vania (ORCID: https://orcid.org/0000-0002-5295-3087)
- Anna Ferrari (ORCID: https://orcid.org/0000-0001-6924-6306)
- Monica Basso (ORCID: https://orcid.org/0000-0003-4575-2129)
- Lolita Sasset
- Alberto Enrico Maraolo (ORCID: https://orcid.org/0000-0002-7218-7762)
- Claudia Cozzolino (ORCID: https://orcid.org/0000-0001-7628-9515)
- Nicola Bonadiman (ORCID: https://orcid.org/0009-0006-3127-5703)
- Anna Maria Cattelan
Institutions
- University of Padua (IT)
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- European journal of medical research
- Published
- 2024-10-04
- DOI
- https://doi.org/10.1186/s40001-024-02062-5
- Citations
- 9
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.50